Home / People / Nick Beckett
Picture of Nick Beckett

Nick Beckett

Managing Partner
Managing Director of Lau, Horton & Wise LLP in Association with CMS Hasche Sigle, Hong Kong LLP and Co-Head of the CMS Life Sciences & Healthcare Group

CMS China
Beijing Representative Office
Room 1909, China Youth Plaza No. 19 Dongsanhuan North Road
Chaoyang District, Beijing 100026
China
Lau, Horton & Wise LLP, in Association with CMS Hasche Sigle, Hong Kong LLP
8th Floor, Nexxus Building, 41 Connaught Road Central,
Hong Kong
CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
London
EC4N 6AF
United Kingdom
Languages English, French

Feed

Show only
June 2018
CMS Guide to Anti-Bribery and Cor­rup­tion Laws
04/07/2019
China Monthly TMT Up­date - June 2019
CAC is­sues Draft Meas­ures for Se­cur­ity As­sess­ment of Cross Bor­der Trans­fer of Per­son­al In­form­a­tion On 13 June 2019, the Cy­ber­space Ad­min­is­tra­tion of China (“CAC”) is­sued the draft Meas­ures for Se­cur­ity As­sess­ment of Cross-Bor­der Trans­fer of Per­son­al In­form­a­tion.
14/06/2019
CAC is­sues Draft Meas­ures for Se­cur­ity As­sess­ment of Cross Bor­der...
On 13 June 2019, the Cy­ber­space Ad­min­is­tra­tion of China (“CAC”) is­sued the draft Meas­ures for Se­cur­ity As­sess­ment of Cross-Bor­der Trans­fer of Per­son­al In­form­a­tion (the “Draft”) for pub­lic com­ment.
13/06/2019
Chinese state coun­cil re­leases reg­u­la­tion on the hand­ling of hu­man...
The State Coun­cil of the People's Re­pub­lic of China (PRC) re­leased the Ad­min­is­trat­ive Reg­u­la­tion on Hu­man Ge­net­ic Re­sources, which de­tails the hand­ing of hu­man ge­net­ic re­sources (i. e. ge­net­ic ma­ter­i­als such as or­gans, tis­sues, cells, gen­omes and genes) and.
28/05/2019
China Life Sci­ences & Health­care Monthly Up­date - April/May 2019
NMPA re­leases draft pro­vi­sions of on-the-spot in­spec­tions for drug re­gis­tra­tion: 17 May 2019 The Na­tion­al Med­ic­al Products Ad­min­is­tra­tion ("NMPA") of the People's Re­pub­lic of China ("PRC") re­leased the draft for the Ad­min­is­trat­ive Pro­vi­sions on On-the-spot.
17/05/2019
China re­leases draft re­vi­sion of the Pat­ent Ex­am­in­a­tion Guidelines
The Na­tion­al In­tel­lec­tu­al Prop­erty Ad­min­is­tra­tion of the People's Re­pub­lic of China re­leased the Draft Re­vi­sion of the Pat­ent Ex­am­in­a­tion Guidelines ("Draft") on 4 April 2019. The Draft was open for pub­lic com­ment un­til 5 May 2019.
30/04/2019
China re­vises the rules on trade secrets in the Anti-Un­fair Com­pet­i­tion...
On 23 April, the Stand­ing Com­mit­tee of the Na­tion­al People’s Con­gress is­sued the Amend­ment of the Anti-Un­fair Com­pet­i­tion Law (“Amend­ment”). The Amend­ment mainly ad­dresses the pro­tec­tion of trade secrets.
29/04/2019
China Monthly TMT Up­date – April 2019
MIIT is­sues Guid­ing Opin­ions on Strength­en­ing Se­cur­ity of the In­dus­tri­al In­ter­net The Min­istry of In­dustry and In­form­a­tion Tech­no­logy (“MIIT”) is­sued Guid­ing Opin­ions on Strength­en­ing Se­cur­ity of the In­dus­tri­al In­ter­net (“Opin­ions”) on 15 April 2019.
29/04/2019
China amends Trade­mark Law to reg­u­late bad-faith re­gis­tra­tion
On 23 April, the amended Trade­mark Law ("Amended Trade­mark Law") was passed by the Stand­ing Com­mit­tee of the Na­tion­al People's Con­gress of the People's Re­pub­lic of China. The Amended Trade­mark Law will take ef­fect on 1 Novem­ber 2019.
28/03/2019
China Quarterly TMT Up­date - Janu­ary/March 2019
TC260 is­sues draft In­form­a­tion Se­cur­ity Tech­no­logy-Per­son­al In­form­a­tion Se­cur­ity Spe­cific­a­tion The Na­tion­al In­form­a­tion Se­cur­ity Stand­ard­isa­tion Tech­nic­al Com­mit­tee (“TC260”) is­sued the In­form­a­tion Se­cur­ity Tech­no­logy-Per­son­al In­form­a­tion Se­cur­ity Spe­cific­a­tion.
25/03/2019
China re­leases the draft Safety Man­age­ment Reg­u­la­tions for Bi­o­tech­no­logy...
The Min­istry of Sci­ence and Tech­no­logy of the People's Re­pub­lic of China re­leased the Safety Man­age­ment Reg­u­la­tions for Bi­o­tech­no­logy Re­search and De­vel­op­ment (Draft for com­ments) ("Draft") on 11 March 2019.
12/03/2019
China Life Sci­ences and Health­care monthly up­date - March 2019
State Coun­cil will de­ploy fur­ther pref­er­en­tial policies for anti-can­cer drugs over 2019, 19 Feb­ru­ary 2019 In an ex­ec­ut­ive meet­ing on 19 Feb­ru­ary 2019, the State Coun­cil of the People's Re­pub­lic of China ("State Coun­cil") an­nounced that six pref­er­en­tial policies.